Latest Trials
Latest News
FAQ
Pharmaceutical Companies
Pharma Details
PALAK SHAH
🇮🇳
India
Country
🇮🇳
India
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News
Evaluation of the Hemocompatibility of the Direct Oral Anti-Coagulant Apixaban in Left Ventricular Assist Devices
Phase 2
Completed
Conditions
Heart Failure
Interventions
Drug: Apixaban
Drug: Warfarin
Device: LVAD implant
Subscribe
First Posted Date
2021-04-29
Last Posted Date
2024-11-14
Lead Sponsor
Palak Shah
Target Recruit Count
30
Registration Number
NCT04865978
Locations
🇺🇸
Inova Fairfax Medical Campus, Falls Church, Virginia, United States
Subscribe
Prev
1
Next
© Copyright 2024. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy